期刊文献+

节律化疗对Lewis肺癌血管生成的影响 被引量:3

Antiangiogenic effect of metronomic chemotherapy on lewis lung carcinoma
下载PDF
导出
摘要 目的观察环磷酰胺(CTX)节律化疗对Lewis肺癌肿瘤血管生成的影响。方法建立荷Lewis肺癌C57BL/6小鼠模型,随机分为CTX节律化疗组、CTX最大耐受剂量(MTD)组和对照组,于造模后第6天开始分别给予相应治疗。观察小鼠饮食、活动及一般状况,连续测量肿瘤大小和小鼠体质量。处死小鼠后,称瘤重,免疫组织化学方法测定各组肿瘤组织的微血管密度(MVD)及血管内皮生长因子(VEGF)表达情况。结果①与MTD组和对照组相比,节律化疗组肿瘤生长曲线较平缓,动物体质量无下降;②实验结束时,节律组、MTD组和对照组的平均瘤重分别为(1.68±0.37)g、(1.94±0.56)g、(3.75±0.86)g;③节律组、MTD组和对照组的MVD分别为15.09±3.03、23.51±2.78和26.38±2.56,VEGF高表达率分别为46.2%、73.5%和81.3%。结论CTX节律化疗可显著抑制Lewis肺癌的生长及其血管生成,且毒副作用较MTD化疗小。 Objective To observe the effects of metronomic chemotherapy with cyclophosphamide(CTX)on tumor angiogenesis on mouse Lewis lung carcinoma model.Methods Lewis lung carcinoma cells were injected subcutaneously into C57BL/6 mice.C57BL/6 mice were randomised into metronomic group,MTD group and control group.According therapy was given to different groups.The general condition of mice was observed every day.Tumor growth and mice weight were monitored during the experiment.At the 25th day after inoculation,all mice were killed.Tumors were resected,weighed and immunohistochemistry was done.Tumor microvessel density(MVD)and vascular endothelial cell growth factor(VEGF)were detected.Results ①Compared to MTD group and control group,the tumor growth curve in metronomic group was near flat and mice in that group had no weight loss.②At the end of experiment,the weight of tumor in metronomic group,MTD group and control group were(3.75±0.86)g,(1.68±0.37)g,(1.94±0.56)g,respectively.②MVD in metronomic group,MTD group and control group were 15.09±3.03,23.51±2.78,26.38±2.56,respectively.The high expression rate of VEGF were 46.2%,73.5%,81.3%,respectively.Conclusion Metronomic chemotherapy with CTX can inhibit the tumor growth and angiogenesis of Lewis lung carcinoma effectively,and it has lower toxicity than MTD chemotherapy.
出处 《中国实用医药》 2007年第36期25-27,共3页 China Practical Medicine
关键词 环磷酰胺 化学疗法 血管新生 Cyclophosphamide Chemothetapy Angiogenesis
  • 相关文献

参考文献8

  • 1[1]Folkman J.Tumor angiogenesis:therapeutic implications.N Engl J Med,1971,285(21):1182-1186.
  • 2[2]Hanahau D,Bergers G,Bergsland E.Less is more,regularly:metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice.J Clin Invest,2000,105 (8):1045-1047.
  • 3[3]Monestiroli S,Mancuso P,Burlini A,et al.Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphomas.Cancer Res,2001,61 (11):4341-4344.
  • 4[4]Weidner N.Intratumor microvessel density as a prognostic factor in cancer.AmJ Path,1995,147:91-92.
  • 5[5]Bocci G,Nicolaou KC,Kerbel RS.Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs.Cancer Res,2002,62 (23):6938-6943.
  • 6[6]Drevs J,Fakler J,Eisele S,et al.Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.Anticancer Res,2004,24 (3):1759-1763.
  • 7张清媛,康欣梅,赵文辉.低剂量环磷酰胺对肺癌肿瘤血管生成的影响[J].实用肿瘤学杂志,2004,18(6):411-413. 被引量:9
  • 8[8]Hanahan D,Bergers G,Bergsland E.Less is more,regularly:metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice.J Clin Invest,2000,105(8):1045-1047.

二级参考文献1

共引文献8

同被引文献22

  • 1沈婕,何胜利,孙贤俊,朱晓娟,高勇.老年晚期胃癌患者卡培他滨节律化疗的临床疗效[J].肿瘤,2010,30(9):788-790. 被引量:18
  • 2王云,梁宪斌,纪媛媛,李醒亚.环磷酰胺节律化疗的抗血管生成作用探讨[J].山东医药,2006,46(6):17-19. 被引量:7
  • 3Enrique LA,Ana Carolina SV,Yadira BC,et al.Phase Ⅱ study of metronomic chemotherapy with thalidomide,carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children[J].Archiv Med Res,2008,39(7):655-662.
  • 4Caballero M,Grau J,Palmero R,et al.Serum vascular endothelial growth factor as prognostic factor in metronomic weekly paclitaxel treatment for patients with advanced head and neck cancer refractory to platinum-based chemotherapy[J].Radiotherapy Oncology,2007,82:33.
  • 5Emmenegger U,Man S,Shaked Y,et al.A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens[J].Cancer Res,2004,64(11):3994-4000.
  • 6J Maris,M Hogarty,R Bagatell,et al.Neuroblastoma.The Lancet, 2007,369:2106-2120.
  • 7Hanahan D, Bergers G,Bergsland E. Less is more,regularly:metro- nomic dosing of cytotoxic drugs can target tumor angiogenesis in mice[J].J Clin Invest, 2000, 105(8) : 1045-1047.
  • 8Park J,Stewart C,London W,et al.A topotecan-containing induction regimen for treatment of high risk neuroblastoma.J Clin Oncol, 2006,24( 18 S):9013.
  • 9Colleoni M . Low dose oralmethotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels [J]. Ann Oncol, 2002,13 (1) : 73-80.
  • 10Beneli R, Monteghirfo S,Balbi C,et al.Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer:hnRNP K as a player[J].Int J Cancer,2009,124(12):2989-2996.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部